Latest News

Many new mothers in the United States face a silent danger after giving birth. Statistics show that most of these deaths are not sudden surprises. They often stem from complications that could be caught early. Yet many mothers report feeling isolated and unsure where to turn for help. The system often expects them to be the first to call, which can feel overwhelming. In Arkansas, a fresh approach is turning the tide. The state launched a reverse‑call program that reaches out to mothers before they have to ask for help. The outreach team uses a list of recent deliveries to schedule calls within 24 to 48 hours after discharge. Nurses and health workers dial numbers from hospital records and check in during the first days after delivery. They ask about pain levels, bleeding, mood, and any si

A new survey at a Japanese university shows a massive gap in HPV vaccine uptake. Only three percent of male students got the shot. Over sixty percent of female students did. The overall rate sits at thirty percent. Researchers asked over three thousand undergrads in April 2025. The difference between sexes is huge and statistically solid. Knowing the vaccine is free makes a big difference. Students who knew that were three and a half times more likely to be vaccinated. Understanding what HPV can cause also helped. For women, knowledge was the only thing that mattered. For men, lifestyle habits like smoking or drinking also played a role. This suggests guys need more than just facts. The study found that knowledge explains part of why men lag behind. Being male links to lower knowledge. L

Scientists studied a germ called Staphylococcus aureus. This germ is the most common cause of infected joints. It also causes surgical site infections. The nose can hold the germ. This is a known risk factor. Still, experts debate routine screening and decolonization. The goal was to lower infection risk. This question guides the research. The study was retrospective. It compared two patient groups. It included 2,507 elective joint replacement procedures. The procedures happened between January 2022 and December 2024. The study took place at one center in Italy. In 2024, patients had nasal swabs. The swabs checked for MSSA and MRSA. Positive patients got a decolonization plan. The plan used mupirocin nasal ointment. It also used chlorhexidine showers. These steps happened before surgery.

A team of analysts looked at Medicare’s standard fee‑for‑service plan. They focused on people aged 66 and older who received cancer‑related care between 2021 and 2023. The goal was to see how virtual visits compared with in‑person appointments across the country. The results showed that video appointments let a few more patients connect with doctors who lived far away. However, most of those virtual sessions still happened within the usual clinic zones. This meant that patients in remote towns did not see a big shift in how far they had to travel for treatment. Because of these patterns, policymakers are urged to think about those who travel the most. They should also make sure patients have reliable internet, easy‑to‑use scheduling tools, and care that can move across state lines. Targe

The world of obesity medicine just got a huge upgrade. Scientists have found that drugs based on GLP-1 proteins are changing how we treat weight. But even though these medicines work well, there are still some big problems. Some people who already have diabetes don't respond as strongly. Others get stomach upset from taking them. And the price tag is really high, which makes many patients stop using the pills. Researchers are now working on smarter versions of these drugs. They're creating mixes that hit more than one hormone at once. Some of these new pills can actually be swallowed instead of injected. Other compounds mimic the body's natural signals without needing shots. The goal is to make the treatments easier to take and safer for more folks. Plus, they want to keep people off the

Herpes simplex encephalitis is a rare but serious brain infection. Doctors usually start treatment with acyclovir right away. Even with that drug, some patients still have bad outcomes. Researchers wanted to see if adding steroids helps. The team used a large Japanese hospital database. They looked at over three thousand patients who got acyclovir within two days of admission. Patients were split into two groups. One group got acyclovir plus intravenous steroids. The other got acyclovir alone. After tracking outcomes, the numbers were striking but nuanced. In-hospital death happened in about four percent of the steroid group and three percent of the other group. The difference was small and not statistically significant. Going home conscious and independent was about the same in both gro

Children who receive growth hormone treatment get asked to answer questionnaires about their daily lives. These tools, known as PROMs, are meant to show how happy and healthy a kid feels. Unfortunately, most doctors do not use them every time they see a patient. This leaves a big hole in tracking how well these treatments work. Researchers went through 50 different surveys found in medical articles and expert discussions. After checking for flaws, they kept 37 strong ones. Twenty-six of these were general surveys covering broad topics, while eleven were specific to growth hormone therapy. Many of these could be filled out by the child themselves or by a parent. Most took less than fifteen minutes to complete. The youngest participants were seven years old, though some studies included ev

Over the past twenty years, the way doctors perform major urologic surgeries has changed a lot. A new study looked at over 54,000 cases from American Board of Urology records between 2000 and 2023. These included surgeries like radical nephrectomy, partial nephrectomy, radical prostatectomy, and others. The big finding? Minimally invasive surgery (MIS), especially robotic-assisted methods, has taken over most of these procedures. Back in the early 2000s, about 75% of these surgeries were done using open techniques. That means surgeons made large cuts to reach the organs. But by 2021-2023, that number dropped to just under 10%. In total, 77% of all cases in the study used minimally invasive approaches. This shift happened across every type of surgery studied. The study also found that sur

Over the last two decades, a huge global marketplace has appeared online. Companies use direct‑to‑consumer ads to sell what they call stem cell therapies that have no solid scientific backing. These products normally never go through the strict government checks that decide if a medical product is safe and works. The ads claim big benefits while the evidence is missing. The result is dangerous. People have died, been injured, lost money, and waited longer for real treatments that are proven. The scams also keep patients away from legitimate clinical trials, hurt the reputation of true stem cell research, and spread confusion about what is real science. Because of these harms, experts warn that the public needs clearer ways to tell trustworthy stem cell options from fake ones. The growin